The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123861304 12386130 4 F 20160802 20160519 20160813 EXP JP-AMGEN-JPNCT2015141456 AMGEN 0.00 M Y 80.10000 KG 20160813 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123861304 12386130 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 480 MG, Q2WK Y 125147 480 MG SOLUTION FOR INJECTION QOW
123861304 12386130 2 SS panitumumab PANITUMUMAB 1 Intravenous drip 480 MG, Q2WK Y 125147 480 MG SOLUTION FOR INJECTION QOW
123861304 12386130 3 SS panitumumab PANITUMUMAB 1 Intravenous drip 480 MG, Q2WK Y 125147 480 MG SOLUTION FOR INJECTION QOW
123861304 12386130 4 SS panitumumab PANITUMUMAB 1 Intravenous drip 4.8 MG/KG, Q2WK Y 125147 4.8 MG/KG SOLUTION FOR INJECTION QOW
123861304 12386130 5 C OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 160 MG, Q2WEEKS U 0 160 MG QOW
123861304 12386130 6 C OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 160 MG, Q2WEEKS U 0 160 MG QOW
123861304 12386130 7 C OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 65 MG/M2, Q2WEEKS U 0 65 MG/M**2 QOW
123861304 12386130 8 C OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 50 MG/M2, Q2WEEKS U 0 50 MG/M**2 QOW
123861304 12386130 9 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 375 MG, Q2WEEKS U 0 375 MG QOW
123861304 12386130 10 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 375 MG, Q2WEEKS U 0 375 MG QOW
123861304 12386130 11 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip UNK, Q2WEEKS U 0 QOW
123861304 12386130 12 C 5-FU FLUOROURACIL 1 Intravenous bolus 750 MG, Q2WEEKS U 0 750 MG QOW
123861304 12386130 13 C 5-FU FLUOROURACIL 1 Intravenous drip 4600 MG, Q2WEEKS U 0 4600 MG QOW
123861304 12386130 14 C 5-FU FLUOROURACIL 1 Intravenous bolus 750 MG, Q2WEEKS U 0 750 MG QOW
123861304 12386130 15 C 5-FU FLUOROURACIL 1 Intravenous drip 4600 MG, Q2WEEKS U 0 4600 MG QOW
123861304 12386130 16 C 5-FU FLUOROURACIL 1 Intravenous bolus 200 MG/M2, Q2WK U 0 200 MG/M**2 QOW
123861304 12386130 17 C 5-FU FLUOROURACIL 1 Intravenous drip 2000 MG/M2, Q2WEEKS U 0 2000 MG/M**2 QOW
123861304 12386130 18 C 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 4600 MG, Q2WEEKS U 0 4600 MG QOW
123861304 12386130 19 C 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 4600 MG, Q2WEEKS U 0 4600 MG QOW
123861304 12386130 20 C 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2000 MG/M2, Q2WEEKS U 0 2000 MG/M**2 QOW

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123861304 12386130 1 Colon cancer
123861304 12386130 5 Colon cancer
123861304 12386130 6 Colon cancer
123861304 12386130 9 Colon cancer
123861304 12386130 10 Colon cancer
123861304 12386130 12 Colon cancer
123861304 12386130 18 Colon cancer

Outcome of event

Event ID CASEID OUTC COD
123861304 12386130 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123861304 12386130 Alopecia
123861304 12386130 Arthralgia
123861304 12386130 Constipation
123861304 12386130 Decreased appetite
123861304 12386130 Dermatitis acneiform
123861304 12386130 Diarrhoea
123861304 12386130 Dry skin
123861304 12386130 Dysgeusia
123861304 12386130 Fatigue
123861304 12386130 Myalgia
123861304 12386130 Nausea
123861304 12386130 Neutrophil count decreased
123861304 12386130 Paronychia
123861304 12386130 Peripheral sensory neuropathy
123861304 12386130 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123861304 12386130 1 20151203 20160104 0
123861304 12386130 2 20160127 20160127 0
123861304 12386130 3 20160219 20160219 0
123861304 12386130 4 20160304 0
123861304 12386130 5 20151203 20160104 0
123861304 12386130 6 20160127 20160127 0
123861304 12386130 7 20160219 20160415 0
123861304 12386130 8 20160506 0
123861304 12386130 9 20151203 20160104 0
123861304 12386130 10 20160127 20160127 0
123861304 12386130 11 20160219 0
123861304 12386130 12 20151203 20160104 0
123861304 12386130 13 20151203 20160104 0
123861304 12386130 14 20160127 20160127 0
123861304 12386130 15 20160127 20160127 0
123861304 12386130 16 20160219 0
123861304 12386130 17 20160219 0
123861304 12386130 18 20151203 20160104 0
123861304 12386130 19 20160127 20160127 0
123861304 12386130 20 20160219 0